Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ongoing HIV replication in cerebrospinal fluid under successful monotherapy.

Antiviral therapy - 1 Jan 2013

Bierhoff Marieke, Boucher Charles A B, Fibriani Azzania, Ten Kate Reinier W

Abstract excerpt

We report a case of an HIV-infected patient who was successfully treated with ritonavir/lopinavir (r/LPV) monotherapy for several years. He presented with neurological symptoms and high HIV RNA levels in cerebrospinal fluid (CSF). Sequencing of the HIV from the CSF revealed mutations in the prote...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to HIV
Share to HIV Protease Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lopinavir

Share to Ritonavir

Share to Sequence Analysis, RNA

Share to Viral Load

Share to Virus Replication

Source

Identifiers

PMID: 23344463
DOI: 10.3851/IMP2530

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23344463-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ongoing HIV replication in cerebrospinal fluid under successful monotherapy.PMID 23344463Read ↗

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.Semantic proximity Read ↗

Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapySemantic proximity Read ↗

Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.Semantic proximity Read ↗

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.Semantic proximity Read ↗

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.Semantic proximity Read ↗

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance.Semantic proximity Read ↗

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.Semantic proximity Read ↗

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.Semantic proximity Read ↗

The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.Semantic proximity Read ↗

Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation.Semantic proximity Read ↗

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapySemantic proximity Read ↗

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.